Nanopublications LDF server

Matches in Nanopublications for { ?s ?p "[Loss of 9p or homozygous deletion of the CDKN2 gene or both are associated with anaplastic oligodendrogliomas, whereas loss of 17p or TP53 gene mutations or both are frequent in astrocytomas, but rare in oligodendrogliomas.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine."@en ?g. }

• NP536989.RAim-BsdbJBHrHaz5doQuXiEUgvgRhzFj6oh_JM85Pfrw130_assertion description "[Loss of 9p or homozygous deletion of the CDKN2 gene or both are associated with anaplastic oligodendrogliomas, whereas loss of 17p or TP53 gene mutations or both are frequent in astrocytomas, but rare in oligodendrogliomas.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP536989.RAim-BsdbJBHrHaz5doQuXiEUgvgRhzFj6oh_JM85Pfrw130_provenance.
• NP180268.RAtV54Jn2ipIalBSPBnG852XyOGVfbvHPMKuhRH7m4sUM130_assertion description "[Loss of 9p or homozygous deletion of the CDKN2 gene or both are associated with anaplastic oligodendrogliomas, whereas loss of 17p or TP53 gene mutations or both are frequent in astrocytomas, but rare in oligodendrogliomas.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP180268.RAtV54Jn2ipIalBSPBnG852XyOGVfbvHPMKuhRH7m4sUM130_provenance.
• NP571549.RA3opGhqaYFb3qZCR31Z3qYbcXD1Pqwq0H2rNTfuSmaa4130_assertion description "[Loss of 9p or homozygous deletion of the CDKN2 gene or both are associated with anaplastic oligodendrogliomas, whereas loss of 17p or TP53 gene mutations or both are frequent in astrocytomas, but rare in oligodendrogliomas.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP571549.RA3opGhqaYFb3qZCR31Z3qYbcXD1Pqwq0H2rNTfuSmaa4130_provenance.
• NP708342.RANBraX9BDozQV4iCCkflqrPQJoNY8wR7th4i4BFBMOUA130_assertion description "[Loss of 9p or homozygous deletion of the CDKN2 gene or both are associated with anaplastic oligodendrogliomas, whereas loss of 17p or TP53 gene mutations or both are frequent in astrocytomas, but rare in oligodendrogliomas.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP708342.RANBraX9BDozQV4iCCkflqrPQJoNY8wR7th4i4BFBMOUA130_provenance.
• NP305917.RABOmvz3jDZN9lB7K9ILNR20wBrr-CRxUdd_4-O9Y4KlM130_assertion description "[Loss of 9p or homozygous deletion of the CDKN2 gene or both are associated with anaplastic oligodendrogliomas, whereas loss of 17p or TP53 gene mutations or both are frequent in astrocytomas, but rare in oligodendrogliomas.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP305917.RABOmvz3jDZN9lB7K9ILNR20wBrr-CRxUdd_4-O9Y4KlM130_provenance.
• NP938361.RAzjeQqmFs229ARwV5BrfWPNIOS5q1qtDHzrw3_AtHiRk130_assertion description "[Loss of 9p or homozygous deletion of the CDKN2 gene or both are associated with anaplastic oligodendrogliomas, whereas loss of 17p or TP53 gene mutations or both are frequent in astrocytomas, but rare in oligodendrogliomas.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP938361.RAzjeQqmFs229ARwV5BrfWPNIOS5q1qtDHzrw3_AtHiRk130_provenance.
• NP911236.RA0CsbpdPBj0RVAZkfE1wJrr_emwiQUM47pxCZYTcoS6A130_assertion description "[Loss of 9p or homozygous deletion of the CDKN2 gene or both are associated with anaplastic oligodendrogliomas, whereas loss of 17p or TP53 gene mutations or both are frequent in astrocytomas, but rare in oligodendrogliomas.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP911236.RA0CsbpdPBj0RVAZkfE1wJrr_emwiQUM47pxCZYTcoS6A130_provenance.
• NP329737.RACZaEofIl0ZbZC9hHXGDbxcIrzVcQN8M6Qzo6VVUhvH8130_assertion description "[Loss of 9p or homozygous deletion of the CDKN2 gene or both are associated with anaplastic oligodendrogliomas, whereas loss of 17p or TP53 gene mutations or both are frequent in astrocytomas, but rare in oligodendrogliomas.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP329737.RACZaEofIl0ZbZC9hHXGDbxcIrzVcQN8M6Qzo6VVUhvH8130_provenance.
• NP301034.RATNPeq2ac8NJBg5xAxegxXQ1FeAFk1jMaIYwMU327jo4130_assertion description "[Loss of 9p or homozygous deletion of the CDKN2 gene or both are associated with anaplastic oligodendrogliomas, whereas loss of 17p or TP53 gene mutations or both are frequent in astrocytomas, but rare in oligodendrogliomas.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP301034.RATNPeq2ac8NJBg5xAxegxXQ1FeAFk1jMaIYwMU327jo4130_provenance.
• assertion description "[Loss of 9p or homozygous deletion of the CDKN2 gene or both are associated with anaplastic oligodendrogliomas, whereas loss of 17p or TP53 gene mutations or both are frequent in astrocytomas, but rare in oligodendrogliomas.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• assertion description "[Loss of 9p or homozygous deletion of the CDKN2 gene or both are associated with anaplastic oligodendrogliomas, whereas loss of 17p or TP53 gene mutations or both are frequent in astrocytomas, but rare in oligodendrogliomas.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• assertion description "[Loss of 9p or homozygous deletion of the CDKN2 gene or both are associated with anaplastic oligodendrogliomas, whereas loss of 17p or TP53 gene mutations or both are frequent in astrocytomas, but rare in oligodendrogliomas.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• assertion description "[Loss of 9p or homozygous deletion of the CDKN2 gene or both are associated with anaplastic oligodendrogliomas, whereas loss of 17p or TP53 gene mutations or both are frequent in astrocytomas, but rare in oligodendrogliomas.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• assertion description "[Loss of 9p or homozygous deletion of the CDKN2 gene or both are associated with anaplastic oligodendrogliomas, whereas loss of 17p or TP53 gene mutations or both are frequent in astrocytomas, but rare in oligodendrogliomas.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• assertion description "[Loss of 9p or homozygous deletion of the CDKN2 gene or both are associated with anaplastic oligodendrogliomas, whereas loss of 17p or TP53 gene mutations or both are frequent in astrocytomas, but rare in oligodendrogliomas.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• NP329735.RA92rPI5OAcdso1IGzU_2W6804eWp_dDD0VP6uqcS7zWY130_assertion description "[Loss of 9p or homozygous deletion of the CDKN2 gene or both are associated with anaplastic oligodendrogliomas, whereas loss of 17p or TP53 gene mutations or both are frequent in astrocytomas, but rare in oligodendrogliomas.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP329735.RA92rPI5OAcdso1IGzU_2W6804eWp_dDD0VP6uqcS7zWY130_provenance.
• NP329738.RAw6wKXaJcssaKQ65vV1p3aZJcexUi4Dha0EM97o2C0Os130_assertion description "[Loss of 9p or homozygous deletion of the CDKN2 gene or both are associated with anaplastic oligodendrogliomas, whereas loss of 17p or TP53 gene mutations or both are frequent in astrocytomas, but rare in oligodendrogliomas.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP329738.RAw6wKXaJcssaKQ65vV1p3aZJcexUi4Dha0EM97o2C0Os130_provenance.
• assertion description "[Loss of 9p or homozygous deletion of the CDKN2 gene or both are associated with anaplastic oligodendrogliomas, whereas loss of 17p or TP53 gene mutations or both are frequent in astrocytomas, but rare in oligodendrogliomas.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• NP300809.RAp2ILJe1BmLj7ALLs5hD-cQN2jH603O7RJNSMziWvomA130_assertion description "[Loss of 9p or homozygous deletion of the CDKN2 gene or both are associated with anaplastic oligodendrogliomas, whereas loss of 17p or TP53 gene mutations or both are frequent in astrocytomas, but rare in oligodendrogliomas.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP300809.RAp2ILJe1BmLj7ALLs5hD-cQN2jH603O7RJNSMziWvomA130_provenance.
• NP300921.RAqFvnfqjfElV7rUKHZvGjNDRDe8IiS0E6gBbQ3MyPGCU130_assertion description "[Loss of 9p or homozygous deletion of the CDKN2 gene or both are associated with anaplastic oligodendrogliomas, whereas loss of 17p or TP53 gene mutations or both are frequent in astrocytomas, but rare in oligodendrogliomas.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP300921.RAqFvnfqjfElV7rUKHZvGjNDRDe8IiS0E6gBbQ3MyPGCU130_provenance.
• NP329736.RAE5QGLEgtTkF1aflrl2FlRxmWbmI5gid9k2MBlNETuLA130_assertion description "[Loss of 9p or homozygous deletion of the CDKN2 gene or both are associated with anaplastic oligodendrogliomas, whereas loss of 17p or TP53 gene mutations or both are frequent in astrocytomas, but rare in oligodendrogliomas.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP329736.RAE5QGLEgtTkF1aflrl2FlRxmWbmI5gid9k2MBlNETuLA130_provenance.
• NP329740.RAEqU-KGalqObSXNH0SpQAAxeE2p-Wc9eqOHjEud12CSw130_assertion description "[Loss of 9p or homozygous deletion of the CDKN2 gene or both are associated with anaplastic oligodendrogliomas, whereas loss of 17p or TP53 gene mutations or both are frequent in astrocytomas, but rare in oligodendrogliomas.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP329740.RAEqU-KGalqObSXNH0SpQAAxeE2p-Wc9eqOHjEud12CSw130_provenance.
• NP329739.RAiUnSbTHvxvJ2pXDk2GQFwXgLdqomEEIvn0KOWfaFZoM130_assertion description "[Loss of 9p or homozygous deletion of the CDKN2 gene or both are associated with anaplastic oligodendrogliomas, whereas loss of 17p or TP53 gene mutations or both are frequent in astrocytomas, but rare in oligodendrogliomas.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP329739.RAiUnSbTHvxvJ2pXDk2GQFwXgLdqomEEIvn0KOWfaFZoM130_provenance.
• NP329741.RAmdL8Bdx2HZG-Dzj4wl1GGaNp7bwNYze9VTkJUGSTe1Q130_assertion description "[Loss of 9p or homozygous deletion of the CDKN2 gene or both are associated with anaplastic oligodendrogliomas, whereas loss of 17p or TP53 gene mutations or both are frequent in astrocytomas, but rare in oligodendrogliomas.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP329741.RAmdL8Bdx2HZG-Dzj4wl1GGaNp7bwNYze9VTkJUGSTe1Q130_provenance.